561
|
|
|
FMR1 autosomal homolog 1 |
CMYO9A, CMYO9B, CMYP9A, CMYP9B, FXR1P, MYOPMIL, MYORIBF |
Anorexia nervosa, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Congenital myopathy, Eating disorder, Gross motor development delay, Insomnia, Intellectual developmental disorder, Mastocytosis, Obesity, Schizophrenia, Scoliosis, Substance abuse, Diabetes mellitus type 2 |
562
|
|
|
FMR1 autosomal homolog 2 |
FMR1L2, FXR2P |
|
563
|
|
|
FXYD domain containing ion transport regulator 1 |
PLM |
|
564
|
|
|
FXYD domain containing ion transport regulator 2 |
ATP1G1, HOMG2 |
|
565
|
|
|
FXYD domain containing ion transport regulator 3 |
MAT8, PLML |
|
566
|
|
|
FXYD domain containing ion transport regulator 4 |
CHIF |
|
567
|
|
|
FXYD domain containing ion transport regulator 5 |
DYSAD, HSPC113, IWU1, KCT1, OIT2, PRO6241, RIC |
|
568
|
|
|
FXYD domain containing ion transport regulator 6 |
- |
|
569
|
|
|
FXYD6-FXYD2 readthrough |
FXYD6 |
|
570
|
|
|
FYN binding protein 1 |
ADAP, FYB, PRO0823, SLAP-130, SLAP130, THC3 |
Central nervous system cancer, Congenital small-platelet thrombocytopenia, Allergic contact dermatitis, Glioblastoma, Glioma, Major depressive disorder, Mood disorder, Nonalcoholic fatty liver disease, Thrombocytopenia, Diabetes mellitus type 2, Vascular dementia |